We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$93.3M
Cap. Flow
-$7.51M
Cap. Flow %
-0.58%
Top 10 Hldgs %
25.17%
Holding
390
New
85
Increased
121
Reduced
146
Closed
8

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.53M
2
DOCU
DocuSign
DOCU
+$1.16M
3
AAPL icon
Apple
AAPL
+$971K
4
MZTI
The Marzetti Company
MZTI
+$858K
5
MSFT icon
Microsoft
MSFT
+$723K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.98%
2 Technology 14.73%
3 Healthcare 13.63%
4 Financials 11.39%
5 Consumer Staples 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IXP icon
376
iShares Global Comm Services ETF
IXP
$506M
$1K ﹤0.01%
+18
New +$1.07K
VPL icon
377
Vanguard FTSE Pacific ETF
VPL
$8.56B
$1K ﹤0.01%
+10
New +$686
EBND icon
378
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$0 ﹤0.01%
+1
New +$27
FOX icon
379
Fox Class B
FOX
$25.8B
$0 ﹤0.01%
+3
New +$101
IGE icon
380
iShares North American Natural Resources ETF
IGE
$770M
$0 ﹤0.01%
+2
New +$58
IXC icon
381
iShares Global Energy ETF
IXC
$2.79B
$0 ﹤0.01%
+12
New +$368
MSGS icon
382
Madison Square Garden
MSGS
$9.38B
-1,402
Closed -$264K
PARA
383
DELISTED
Paramount Global Class B
PARA
-8,023
Closed -$324K
SCHX icon
384
Schwab US Large- Cap ETF
SCHX
$74.3B
-30,828
Closed -$364K
SHV icon
385
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$0 ﹤0.01%
+2
New +$221
VRSN icon
386
VeriSign
VRSN
$26.4B
-1,260
Closed -$238K
MRTX
387
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-4,300
Closed -$335K
RDS.A
388
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-5,290
Closed -$311K
AABA
389
DELISTED
Altaba Inc
AABA
-29,954
Closed -$584K
CELG
390
DELISTED
Celgene Corp
CELG
-25,435
Closed -$2.53M

Similar funds

Dowling & Yahnke's Q4 2019 Portfolio in Review

As of Q4 2019, Dowling & Yahnke held 390 positions worth $1.3B, up 7.7% from $1.21B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dowling & Yahnke's Q4 2019 filing shows 85 new, 121 increased, 146 reduced and 8 closed positions. Its largest new stake was iShares National Muni Bond ETF: 4,701 shares worth $535K. The largest sale was Celgene Corp, an estimated $2.53M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q4 2019 buy was iShares National Muni Bond ETF: 4,701 shares worth $535K.
  • Dowling & Yahnke added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.6M increase.
  • Dowling & Yahnke's biggest Q4 2019 reduction was DocuSign, cutting an estimated $1.16M.
  • Dowling & Yahnke fully exited Celgene Corp in Q4 2019, selling an estimated $2.53M.
  • Dowling & Yahnke's ten largest holdings make up 25% of its $1.3B portfolio in Q4 2019.
  • Dowling & Yahnke opened 85 new positions and closed 8 in Q4 2019.
  • Dowling & Yahnke's portfolio value rose 7.7% quarter-over-quarter to $1.3B.

Based on Dowling & Yahnke's 13F filing for Q4 2019, filed 27 Jan 2020.